PLUS1
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 13.97 | 0.00 | 0.00 | 0.00 | 13.97 | 06:59:43 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 13.68 | 14.75 | 1.07 | 7.25% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Verrica Parmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 359.61M | 25.74M | $ -20.65M | -1.37 | - | 14.68M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -27.00 | 43.00% |
Verrica Parmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/21/2019 | 16:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 10/21/2019 | 16:49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 10/18/2019 | 07:10 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/18/2019 | 07:00 | GlobeNewswire Inc. | Verrica Pharmaceuticals Announces Presentation of Positive.. |
| 10/10/2019 | 17:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 10/10/2019 | 16:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/09/2019 | 07:00 | GlobeNewswire Inc. | Verrica Pharmaceuticals Appoints Eugene Scavola to the.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRCA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.35 | 15.72 | 13.77 | 14.48 | 74,153 | -1.38 | -8.99% |
| 1 Month | 12.27 | 15.94 | 12.00 | 14.47 | 69,369 | 1.70 | 13.85% |
| 3 Months | 11.71 | 15.94 | 8.39 | 13.16 | 54,628 | 2.26 | 19.3% |
| 6 Months | 9.61 | 15.94 | 6.84 | 11.65 | 50,792 | 4.36 | 45.37% |
| 1 Year | 13.10 | 15.94 | 6.44 | 11.49 | 51,810 | 0.87 | 6.64% |
| 3 Years | 20.00 | 23.29 | 6.44 | 13.30 | 58,341 | -6.03 | -30.15% |
| 5 Years | 20.00 | 23.29 | 6.44 | 13.30 | 58,341 | -6.03 | -30.15% |
Verrica Parmaceuticals Description
| Verrica Pharmaceuticals Inc a clinical-stage biopharmaceutical company. The company is primarily focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its pipeline product includes NCT03377803, and NCT03377790. |
